$Spark New Zealand Ltd (SPK.AU)$ This crappy stock is doomed

$Elevra Lithium Ltd (ELV.AU)$ Financing has caught up with the eighteen-month critical mineral deregulation...

$Botanix Pharmaceuticals Ltd (BOT.AU)$  d
I'm holding this stock for a year with 100k shares at an average cost of 0.35, and I believe it will have good development

$Botanix Pharmaceuticals Ltd (BOT.AU)$
All we need here is ramp us sales figure. atleast 36k for next quarter and 45k prescription in october quarter. It has history of up and down. By any chanse if we can achieve GTN 30% by Q4 we will have revenue of 19.5 million. This could help us to achive breakeven. There is still chanse to upgrade BOT to tier 2 by us insurance companies where we can expect Gtn at around 35% with atleast 20% more sales figure. DYOR.

$Nickel Industries Ltd (NIC.AU)$ looking very interesting at the moment. A close above $1.11 could be a good buying opportunity.

$Elevra Lithium Ltd (ELV.AU)$ The financing price at 12.2 is still acceptable

$Aristocrat Leisure Ltd (ALL.AU)$ Each one of them is like a hawk that won't act until the rabbit is in sight

$Botanix Pharmaceuticals Ltd (BOT.AU)$
Could be nice come back story from here.
We are fundamentally good. If SP trade above 6 cent by the end of this year we will never be in this position in future. We have everything now. 50 million cash, new API that can prevent from US tarrif tax ,new COO, 50 sales team and fda approved world class Sofdra to sales along with strong phase 3 products in pipeline. By any chanse if we can acess 45 million $ by SPP then potential shareholders have confident and ...

$CSL Ltd (CSL.AU)$ previously I said I'd buy at $100. Revising that to $50.

$Syrah Resources Ltd (SYR.AU)$ Amazing， 0.110 strong support finally broken